Viewing Study NCT04523857


Ignite Creation Date: 2025-12-24 @ 6:58 PM
Ignite Modification Date: 2025-12-28 @ 10:17 AM
Study NCT ID: NCT04523857
Status: RECRUITING
Last Update Posted: 2025-04-04
First Post: 2020-08-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer
Sponsor: Abramson Cancer Center at Penn Medicine
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module